Boenning & Scattergood’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $634K | Buy |
2,428
+300
| +14% | +$78.3K | 0.1% | 221 |
|
|
2022
Q3 | $616K | Hold |
2,128
| – | – | 0.13% | 188 |
|
|
2022
Q2 | $600K | Sell |
2,128
-300
| -12% | -$84.6K | 0.11% | 197 |
|
|
2022
Q1 | $634K | Buy |
2,428
+900
| +59% | +$235K | 0.1% | 221 |
|
|
2021
Q4 | $336K | Buy |
1,528
+50
| +3% | +$11K | 0.05% | 306 |
|
|
2021
Q3 | $268K | Sell |
1,478
-50
| -3% | -$9.07K | 0.05% | 320 |
|
|
2021
Q2 | $308K | Sell |
1,528
-1,089
| -42% | -$220K | 0.05% | 301 |
|
|
2021
Q1 | $562K | Buy |
2,617
+34
| +1% | +$7.3K | 0.11% | 214 |
|
|
2020
Q4 | $610K | Buy |
2,583
+1,136
| +79% | +$268K | 0.13% | 176 |
|
|
2020
Q3 | $394K | Buy |
1,447
+11
| +0.8% | +$3K | 0.09% | 213 |
|
|
2020
Q2 | $417K | Buy |
+1,436
| New | +$417K | 0.11% | 195 |
|